• picture

What is NEO-CIRC?

Neo-Circ Consortium


- will focus on the use of the drug dobutamine for the treatment of circulatory failure in the first two days after birth

- sustained low blood pressure and impaired blood flow to organs, during this period, can cause brain injury resulting in poor neurodevelopmental outcomes

- neurodevelopmental disorders are associated with mental, emotional and physical disorders of varying severity

- there is strong evidence that the use of dobutamine will reduce the incidence of these disabilities


Latest news

NEOCIRC001 trials recruits the 1st baby
LaPaz Hospital in Spain recruits the 1st bady to enter the NEOCIRC001 clinical trial.

NEOCIRC-001 trial opening
The first clinical trial of the project, NEOCIRC-001 is ready to open in Madrid and Brighton.

Electronic system set up for the clinical trials data management
An electronic web-based system for capture and management of the trial data has been developed by the partner Hannover Medical School (MHH).

View all news >>


4th NEO-CIRC Consortium Meeting

The 4th NEO-CIRC Consortium Meeting to take place in the city of Cluj-Napoca in Romania.

NEO-CIRC Consortium Meeting Scheduled

The next NEO-CIRC Consortium Meeting will be held in Lübeck, Germany on the 19th – 20th March 2013.

NEO-CIRC Consortium Meeting held in Madrid.

The first consortium meeting was held in Madrid on the 12-13th June 2012. The meeting was hosted by NEO-CIRC partner- Servicio Madrileño De Salud (Sermas).

View all events >>